Yendou is a Berlin-based provider of a clinical operations automation platform designed to accelerate the operational efficiency of clinical trials. Led by CEO and co-founder Zina Sarif and co-founder Patrick Rogg, the company launched in March 2023. Since launch it has gathered adoption from over 1,200 clinicians across 46 countries. After initial clinician traction, Yendou opened a closed beta of its platform for pharmaceutical and biotech companies to connect, select, and onboard clinical trial sites for Phase II and Phase III oncology trials. The company intends to use the funds to expand operations and advance its development efforts.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Feb 2024